When we think of plagues, we think of AIDS, Ebola, anthrax spores, and, of course, the Black Death. But in 1918 the Great Flu Epidemic killed an estimated 40 million people virtually overnight. If such a plague returned today, taking a comparable percentage of the U.S. population with it, 1.5 million Americans would die.

In Flu, Gina Kolata, an acclaimed reporter for The New York Times, unravels the mystery of this lethal virus with the high drama of a great adventure story. From Alaska to Norway, from the streets of Hong Kong to the corridors of the White House, Kolata tracks the race to recover the live pathogen and probes the fear that has impelled government policy.

A gripping work of science writing, Flu addresses the prospects for a great epidemic's recurrence and considers what can be done to prevent it.

'It's rare to find a professional in the field of health care who understands the psychology of such a frightening experience and who has also been through it herself. Cordelia's book will ring true to every woman who has experienced breast cancer and will, I hope, offer insight to doctors and nurses.' - From the foreword by Jenni Murray OBE What is it like to experience breast cancer? This book presents rare and valuable insights into the impact of diagnosis, treatment and prognosis from a woman who has experienced breast cancer as both patient and as health professional. It informs and educates readers about the psychological realities of living with breast cancer, of treatments such as surgery and radiotherapy, and the impact of social and historical attitudes to the breast and breast cancer on a woman's experience of the disease. The conflicts Cordelia Galgut experienced between conventional wisdom and her own first-hand experience are explored vividly and reflectively. The Psychological Impact of Breast Cancer is vital reading for medical and mental health professionals and trainees working with breast cancer patients, and for those who are affected by or have an interest in the condition. 'The aim of this book, and the way forward, is to understand that we must all be more sensitive to the feelings of patients and to the suffering, uncertainty and sense of vulnerability that this disease imposes upon them.' - Dr Carmel Coulter in her Foreword 'This book has helped me understand the complexities that my patients present and has turned me into a better doctor. It has eased my way along the road that I now travel as a cancer survivor.' - Dr Cathy Roberts in her Foreword ]

First Prize, BMA Medical Book Awards 2013 Breast cancers are now detected earlier and are thus more likely to be confined to the breast itself and regional nodes. Many of these tumours will have minimal proclivity for hematogenous dissemination and formation of micrometastases. On the other hand, some patients have micrometastatic diseases which can remain dormant and be activated many years after initial diagnosis. Early Breast Cancer: From Screening to Multidisciplinary Management discusses the principles and practice of breast cancer management with respect to both screen-detected and symptomatic disease. It provides readers with sound understanding and critical insight into many aspects of the disease from epidemiology, genetics, and screening to pathology, diagnosis, treatment, and prevention. This latest edition continues the general ethos of the second edition with an emphasis on early screening and continued development of the multidisciplinary team.

The world of medicine has become splintered into two factions, that of orthodoxy and its counterpart, alternative or complementary medicine. A problem with alternative medicine is, of course, that of anecdote and hearsay. The solution: the disclosure, in an unassailable fashion, of the underlying biochemical principles for alternative cancer therapies. Cancer and the Search for Selective Biochemical Inhibitors, Second Edition delineates the underlying biochemical principles for alternative cancer therapies. Completely revised and updated, this edition includes coverage of the link between concepts and practices of alternative and conventional medicine. The author examines anticancer plant substances and other alternatives such as Vitamin C, essiac tea, shark cartilage, and cat's claw. The text also addresses the problem of determining selective and non-toxic enzyme inhibitors for cancer cell metabolic pathways. While an increased number of allopathic professionals are in tune with alternative therapies, the integration of the two factions is far from the norm. Keeping the same format that made its predecessor a benchmark text, this book compares complementary, alternative, and integrative treatments with chemotherapy and other more traditional treatments.

It is now widely accepted that there are important links between inactivity and lifestyle-related chronic diseases, and that exercise can bring tangible therapeutic benefits to people with long-term chronic conditions. Exercise and Chronic Disease: An Evidence-Based Approach offers the most up-to-date survey currently available of the scientific and clinical evidence underlying the effects of exercise in relation to functional outcomes, disease-specific health-related outcomes and quality of life in patients with chronic disease conditions.

Drawing on data from randomized controlled trials and observational evidence, and written by a team of leading international researchers and medical and health practitioners, the book explores the evidence across a wide range of chronic diseases, including:

• cancer
• heart disease
• stroke
• diabetes
• parkinson's disease
• multiple sclerosis
• asthma.

Each chapter addresses the frequency, intensity, duration and modality of exercise that might be employed as an intervention for each condition and, importantly, assesses the impact of exercise interventions in relation to outcomes that reflect tangible benefits to patients. No other book on this subject places the patient and the evidence directly at the heart of the study, and therefore this book will be essential reading for all exercise scientists, health scientists and medical professionals looking to develop their knowledge and professional practice.

It is now widely accepted that there are important links between inactivity and lifestyle-related chronic diseases, and that exercise can bring tangible therapeutic benefits to people with long-term chronic conditions. Exercise and Chronic Disease: An Evidence-Based Approach offers the most up-to-date survey currently available of the scientific and clinical evidence underlying the effects of exercise in relation to functional outcomes, disease-specific health-related outcomes and quality of life in patients with chronic disease conditions. Drawing on data from randomized controlled trials and observational evidence, and written by a team of leading international researchers and medical and health practitioners, the book explores the evidence across a wide range of chronic diseases, including: cancer heart disease stroke diabetes parkinson's disease multiple sclerosis asthma. Each chapter addresses the frequency, intensity, duration and modality of exercise that might be employed as an intervention for each condition and, importantly, assesses the impact of exercise interventions in relation to outcomes that reflect tangible benefits to patients. No other book on this subject places the patient and the evidence directly at the heart of the study, and therefore this book will be essential reading for all exercise scientists, health scientists and medical professionals looking to develop their knowledge and professional practice.

For those who could read between the lines, the censored news out of China was terrifying. But the president insisted there was nothing to worry about. Fortunately, we are still a nation of skeptics. Fortunately, there are those among us who study pandemics and are willing to look unflinchingly at worst-case scenarios.

Michael Lewis’s taut and brilliant nonfiction thriller pits a band of medical visionaries against the wall of ignorance that was the official response of the Trump administration to the outbreak of COVID-19. The characters you will meet in these pages are as fascinating as they are unexpected.

A thirteen-year-old girl’s science project on transmission of an airborne pathogen develops into a very grown-up model of disease control. A local public-health officer uses her worm’s-eye view to see what the CDC misses, and reveals great truths about American society. A secret team of dissenting doctors, nicknamed the Wolverines, has everything necessary to fight the pandemic: brilliant backgrounds, world-class labs, prior experience with the pandemic scares of bird flu and swine flu…everything, that is, except official permission to implement their work.

Michael Lewis is not shy about calling these people heroes for their refusal to follow directives that they know to be based on misinformation and bad science. Even the internet, as crucial as it is to their exchange of ideas, poses a risk to them. They never know for sure who else might be listening in.

Are you looking for concise, practical answers to questions that are often left unanswered by traditional cancer references that are not designed for gastroenterologists? Are you seeking brief, evidence-based advice for complicated cases or patients with complications that need management? Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides quick and direct answers to the thorny questions commonly posed during a "curbside consultation" between colleagues. Dr. Douglas G. Adler has designed this unique reference, which offers expert advice, preferences, and opinions on tough clinical questions commonly associated with GI cancer. The unique Q&A format provides quick access to current information related to GI cancer with the simplicity of a conversation between two colleagues. Numerous images, diagrams, and references are included to enhance the text and to illustrate the treatment of GI cancer patients. Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides information basic enough for residents while also incorporating expert advice that even high-volume clinicians will appreciate. Gastroenterologists, fellows and residents in training, surgical attendings, and surgical residents will benefit from the user-friendly and casual format and the expert advice contained within. Some of the questions that are answered: * An 81-year-old man is found to have unresectable esophageal cancer and malignant dysphagia. Should he have a stent? A nasogastric feeding tube? A PEG tube? * How is tumor-related bleeding from gastric cancers best approached? * Do patients with pancreatic cancer and jaundice need to have an ERCP preoperatively? * What is the role of ERCP and EUS in patients with suspected cholangiocarcinoma? * Why are rectal cancers so different from colon cancers with regards to medical and surgical management? Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions illustrates how patients at different points in their treatment may go back and forth between specialists to receive coordination of care, and incorporates input from gastroenterologists, surgeons, radiologists, and oncologists. While providing up-to-date information, this book will help gastroenterologists to manage complex cancer-related issues and guide physicians through the maze of cancer-related treatments available. Ideal for practicing gastroenterologists, gastroenterology fellows, surgeons, oncologists, residents, and medical students, Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions is sure to benefit anyone caring for patients with gastrointestinal cancers.

Part of the "What Do I Do Now?: Palliative Care" series, Pain uses thought-provoking, real-world cases to illustrate concepts, approaches to therapy, and potential barriers to optimal care presented by a diverse panel of interdisciplinary authors. Pain is a frequent and distressing symptom encountered by those with serious or life-limiting illness and may present in a multitude of fashions and from a wide array of etiologies. This book intertwines pharmacologic, nonpharmacologic, and ethical principles of pain control within case-based discussions, allowing readers to expect: * Unique perspectives of pain control, from numerous essential members of the healthcare team; * An engaging collection of cases that illustrate the most current approaches to the most commonly encountered pain syndromes in palliative care; * Chapters that begin with cases and that utilize a conversational tone throughout, like a "curb-side" consult with a seasoned colleague. Consisting of 46 chapters that cover everything from antidepressants to cannabis, cultural competency to bone pain, this volume is also a self-assessment tool that tests the reader's ability to answer the question, "What do I do now?"

Lymphomas classically manifest themselves in the lymph nodes but can also present in other bodily tissues or systems; the organ where exactly they present may make a very great difference to the strategy that should be adopted for their management. This topic has only recently been consistently addressed as an issue on its own, apart from the rest of the lymphomas, and this text is the first to apply modern systems of classification, diagnosis and management. This text is essential reading for hematologic oncologists and hematopathologists.

Explore important research approaches and concepts within diagnostic radiography Provide contemporary evidence-based practice regarding mixed method approaches Provide a clear and 'how to guide' for understanding key research principles in a wide range of radiographic settings Evaluate the impact of research on patients and the radiographer-patient relationship

In the early 1980s it was discovered that HIV, the virus that causes AIDS, could be passed through a mother's milk to her baby. Almost overnight in the industrialised countries, and later in the African countries most ravaged by HIV, breastfeeding became an endangered practice. But in the rush to reduce transmission of HIV, everything we already knew about breastfeeding's life-saving effects was overlooked, with devastating consequences for mothers and babies. In HIV and Breastfeeding - the untold story, former IBCLC Pamela Morrison, an acknowledged authority on HIV and breastfeeding, reveals how women in the world's most poverty-stricken areas were persuaded to abandon breastfeeding as part of a short-sighted and deadly policy that led to an humanitarian disaster. The dilemma that breastfeeding, an act of nurturing which confers food, comfort and love, could be at once life-saving yet lethal, has been called 'the ultimate paradox'. This critical account reveals how vital breastfeeding is, even in the most difficult of circumstances, and examines the lessons that can be learned from the mistakes of the past - which is particularly relevant as we deal with the consequences for mothers and babies of another global pandemic, Covid-19. With detailed information for HIV-positive mothers and their caregivers, and success stories from mothers themselves, this book is essential reading for anyone involved in protecting and supporting breastfeeding, or with a need for evidence-based information about breastfeeding and HIV.

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to "molecules and cells that negatively regulate T-cell activation". Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases. Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

Common factors that lead to treatment failure in head and neck cancer are the lack of tumour oxygenation, the accelerated division of cancer cells during treatment, and radioresistance. These tumour-related challenges and possible ways to overcome them are covered in this book, authored by three medical physicists and a clinical oncologist who explain how different radiobiological findings have led to the development of various treatment techniques for head and neck cancer. Novel treatment techniques as supported by current scientific evidence are comprehensively explored, as well as the major challenges that arise in the retreatment of patients who have already undergone a form of radiotherapy for primary head and neck cancer. Features: Uses an interdisciplinary approach, encompassing clinical aspects of radiotherapy, radiation biology, and medical physics Applies content by relating all radiobiological characteristics to their respective clinical implications Explains the radiobiological rationale for all previous and current clinical trials for head and neck cancer

Addressing a major field of interest for oncologists, cell biologists, and other biomedical researchers, Beyond Apoptosis provides an overview of how different biological mechanisms of cell death, senescence and mitotic catastrophe stop the growth of tumor cells treated with anticancer agents. Written by internationally renowned contributors, this text includes: morphological illustrations, as well as a DVD containing documents and video clips from various time-lapse microscopic studies of cell death and mitotic catastrophe the role and limitations of apoptosis as a determinant of the toxicity of anticancer agents alternative mechanisms of the antiproliferative actions of anticancer drugs and radiation, such as non-apoptotic cell death, cell senescence, and mitotic catastrophe non-apoptotic forms of cell death, such as necrosis, paraptosis, autophagic cell death, and others morphological and kinetic differences of the various forms of cell death

Integrative Oncology explores a comprehensive, evidence-based approach to cancer care that addresses all individuals involved in the process, and can include the use of complementary and alternative medicine (CAM) therapies alongside conventional modalities such as chemotherapy, surgery, and radiation therapy. The number of integrative care programs is increasing worldwide and this book forms a foundation text for all who want to learn more about this growing field. This guide provides a thoughtful and generous perspective on integrative care, an outstanding overview of the exciting clinical opportunities these techniques can offer, and a guide to the new territories that all oncologists and CAM practitioners need to explore and understand.

This book summarizes the etiology, presentation, and treatment of the complex symptoms, infections, and opportunistic cancers of people living with HIV/AIDS. With contributions from nearly 25 clinicians and citing more than 1200 references to support and elaborate on text material, AIDS-Related Cancers and Their Treatment is a crucial reference for all clinical specialists involved.

Hadron therapy is a groundbreaking new method of treating cancer. Boasting greater precision than other therapies, this therapy is now utilised in many clinical settings and the field is growing. More than 50 medical facilities currently perform (or are planned to perform) this treatment, with this number set to double by 2020. This new text covers the most recent advances in hadron therapy, exploring the physics, technology, biology, diagnosis, clinical applications, and economics behind the therapy. Providing essential and up-to-date information on recent developments in the field, this book will be of interest to current and aspiring specialists from a wide range of backgrounds. Features: Multidisciplinary approach: explores the physics, IT (big data), biology, clinical applications from imaging to treatment, clinical trials, and economics associated with hadron therapy Contains the latest research and developments in this rapidly evolving field, and integrates them into the current global challenges for radiation therapy Edited by recognised leaders in the field, including the co-ordinator of ENLIGHT (the European Network for Light Ion Hadron Therapy), with chapter contributions from international leading experts in the field

In cancer research, a traditional phase II trial is designed as a single-arm trial that compares the experimental therapy to a historical control. This simple trial design has led to several adverse issues, including increased false positivity of phase II trial results and negative phase III trials. To rectify these problems, oncologists and biostatisticians have begun to use a randomized phase II trial that compares an experimental therapy with a prospective control therapy. Randomized Phase II Cancer Clinical Trials explains how to properly select and accurately use diverse statistical methods for designing and analyzing phase II trials. The author first reviews the statistical methods for single-arm phase II trials since some methodologies for randomized phase II trials stem from single-arm phase II trials and many phase II cancer clinical trials still use single-arm designs. The book then presents methods for randomized phase II trials and describes statistical methods for both single-arm and randomized phase II trials. Although the text focuses on phase II cancer clinical trials, the statistical methods covered can also be used (with minor modifications) in phase II trials for other diseases and in phase III cancer clinical trials. Suitable for cancer clinicians and biostatisticians, this book shows how randomized phase II trials with a prospective control resolve the shortcomings of traditional single-arm phase II trials. It provides readers with numerous statistical design and analysis methods for randomized phase II trials in oncology.

Rapid advances in nanotechnology have enabled the fabrication of nanoparticles from various materials with different shapes, sizes, and properties, and efforts are ongoing to exploit these materials for practical clinical applications. Nanotechnology is particularly relevant in the field of oncology, as the leaky and chaotic vasculature of tumors-a hallmark of unrestrained growth-results in the passive accumulation of nanoparticles within tumors. Cancer Nanotechnology: Principles and Applications in Radiation Oncology is a compilation of research in the arena of nanoparticles and radiation oncology, which lies at the intersection of disciplines as diverse as clinical radiation oncology, radiation physics and biology, nanotechnology, materials science, and biomedical engineering. The book provides a comprehensive, cross-disciplinary survey of basic principles, research techniques, and outcomes with the goals of eventual clinical translation. Coverage includes A general introduction to fabrication, preferential tumor targeting, and imaging of nanoparticles The specific applications of nanomaterials in the realms of radiation therapy, hyperthermia, thermal therapy, and normal tissue protection from radiation exposure Outlooks for future research and clinical translation including regulatory issues for ultimate use of nanomaterials in humans Reflecting profound advances in the application of nanotechnology to radiation oncology, this comprehensive volume demonstrates how the unique physicochemical properties of nanoparticles lead to novel strategies for cancer treatment and detection. Along with various computational and experimental techniques, each chapter highlights the most promising approaches to the use of nanoparticles for radiation response modulation.

Propelling quantitative MRI techniques from bench to bedside, Quantitative MRI in Cancer presents a range of quantitative MRI methods for assessing tumor biology. It includes biophysical and theoretical explanations of the most relevant MRI techniques as well as examples of these techniques in cancer applications. The introductory part of the book covers basic cancer biology, theoretical aspects of NMR/MRI physics, and the hardware required to form MR images. Forming the core of the book, the next three parts illustrate how to characterize tissue properties with endogenous and exogenous contrast mechanisms and discuss common image processing techniques relevant for cancer. The final part explores emerging areas of MR cancer characterization, including radiation therapy planning, cellular and molecular imaging, pH imaging, and hyperpolarized MR. Each of the post-introductory chapters describes the salient qualitative and quantitative aspects of the techniques before proceeding to preclinical and clinical applications. Each chapter also contains references for further study. Leading the way toward more personalized medicine, this text brings together existing and emerging quantitative MRI techniques for assessing cancer. It provides a self-contained overview of the theoretical and experimental essentials and state of the art in cancer MRI.

Chemical Intolerance identifies phenolic (aromatic) chemical compounds present in natural foodstuffs, pollens, certain food additives, tobacco smoke, perfumes, air pollution, etc., as nonimmunologic, but pharmacologic activators of allergic reactions in chemically intolerant individuals. Biochemical pathway sequences, with supporting scientific literature, are outlined to elucidate the mechanisms associated with formation of inflammatory mediators (prostaglandins, thromboxanes, and leukotrienes) upon activation by phenolic compounds and other chemical stimulants. The role of these inflammatory agents in respiratory, gastrointestinal, neurological, cardiovascular, and other disorders is discussed. Treatment modalities using precise dosages of selected phenolic compounds are outlined to provide clinicians with an effective means of therapy. The author also shares his own experience and personal findings based on 20 years of research, including his recommendations for therapy.

First Published in 1988, this book offers a full, comprehensive guide into the relationship between macrophages and Cancer. Carefully compiled and filled with a vast repertoire of notes and references this book serves as a useful reference for Students of Medicine, Oncology and other practitioners in their respective fields.

Gain mastery over the fundamentals of radiation oncology physics! This package gives you over 60 tutorial videos (each 15-20 minutes in length) with a companion text, providing the most complete and effective introduction available. Dr. Ford has tested this approach in formal instruction for years with outstanding results. The text includes extensive problem sets for each chapter. The videos include embedded quizzes and "whiteboard" screen technology to facilitate comprehension. Together, this provides a valuable learning tool both for training purposes and as a refresher for those in practice. Key Features A complete learning package for radiation oncology physics, including a full series of video tutorials with an associated textbook companion website Clearly drawn, simple illustrations throughout the videos and text Embedded quiz feature in the video tutorials for testing comprehension while viewing Each chapter includes problem sets (solutions available to educators)

This book offers an accessible and up-to-date reference on primate zoonoses. Recent years have witnessed a rise in human diseases zoonotically transferred from animals, with wild primates implicated in the spread of numerous newly emerging infections. The authors go beyond simply providing an inventory of diseases, helping readers to understand how and why they are transmitted. Important consideration is given to the contemporary cultural and ecological factors involved.